Skip to main content
. 2021 Feb 4;7:3. doi: 10.1038/s41514-021-00055-w

Table 1.

Characteristics of the study subjects.

Parameters NC (n = 81) MCI (n = 108) Dementia (n = 81)
Total p AD (n = 47) p VaD (n = 18) p OD (n = 16) p
Gender (male/female) 38/43 42/66 38/43 0.617 22/25 0.392 8/10 0.537 8/8 0.542
Age, years 80.00 (73.50–85.00) 76.00 (73.00–81.00) 82.00 (75.50–85.00)#& <0.001 82.00 (77.00–82.00) <0.001 79.50 (74.25–84.25) 0.039 81.00 (74.00–84.75) 0.039
BMI, kg/m2 23.24 (20.96–25.62) 23.81 (21.52–26.70) 22.50 (20.84–24.45) 0.072 22.46 (20.76–23.81) 0.053 24.10 (20.89–26.96) 0.580 22.65 (21.69–24.01) 0.372
Levels of education, n (%) <0.001 <0.001 0.001 <0.001
Illiteracy 10 (12.80) 45 (42.90) 8 (10.70)#$ 7 (15.20) 0 (0.00) 1 (6.30)
Primary school 30 (38.50) 26 (24.80) 20 (27.70) 9 (19.60) 9 (69.20) 2 (12.50)
Middle school 16 (20.50) 12 (11.40) 9 (12.00) 3 (6.50) 2 (15.40) 4 (25.00)
High school 6 (7.70) 13 (12.40) 5 (6.70) 4 (8.70) 0 (0.00) 1 (6.30)
College or University or above 16 (20.50) 9 (8.60) 33 (44.00) 23 (50.00) 2 (15.40) 8 (50.00)
Smoking, n (%) 23 (28.40) 28 (25.90) 23 (29.90) 0.832 10 (21.70) 0.851 7 (46.70) 0.250 6 (37.50) 0.871
Drinking, n (%) 21 (25.90) 28 (25.90) 16 (19.80) 0.554 7 (14.90) 0.284 5 (27.80) 0.986 4 (25.00) 0.997
Habit of salt intake <0.001 0.180 0.143 0.199
High 23 (28.40) 37 (34.30) 8 (9.90)&$ 4 (8.50) 3 (16.70) 1 (6.30)
Normal 20 (24.70) 36 (33.30) 58 (71.60) 37 (78.70) 7 (38.90) 14 (87.50)
Low 38 (46.90) 35 (32.40) 15 (18.50) 6 (12.80) 8 (44.40) 1 (6.30)
Family history of dementia, n (%) 2 (2.50) 6 (5.60) 7 (8.60) 0.260 5 (10.60) 0.150 1 (5.60) 0.570 1 (6.30) 0.552
Hypertension, n (%) 51 (63.00) 67 (62.00) 58 (71.60) 0.347 32 (68.10) 0.606 15 (83.30) 0.209 11 (68.80) 0.992
Diabetes, n (%) 18 (22.20) 36 (33.30) 28 (34.60) 0.160 18 (38.30) 0.113 7 (38.90) 0.167 3 (18.80) 0.170
Depression, n (%) 2 (2.50) 2 (1.90) 7 (8.60) 0.084 4 (8.50) 0.094 1 (5.60) 0.639 2 (12.50) 0.060
Ischemic stroke, n (%) 20 (24.70) 30 (27.80) 47 (58.00)&$ <0.001 26 (55.30) 0.002 13 (72.20) <0.001 8 (50.00) 0.037
Malignant tumor, n (%) 2 (2.50) 1 (0.90) 5 (6.20) 0.132 3 (6.40) 0.141 1 (5.60) 0.379 1 (6.30) 0.326
Cardiovascular disease, n (%) 22 (27.20) 37 (34.30) 27 (33.30) 0.551 18 (38.30) 0.385 4 (22.20) 0.423 5 (31.30) 0.582
FBG, mmol/L 5.09 (4.65–6.19) 5.48 (4.73–6.66) 5.10 (4.50–5.90) 0.049 5.20 (4.50–5.90) 0.165 4.15 (2.19–5.00) 0.003 5.55 (4.80–5.88) 0.219
SBP, mmHg 137.00 (125.00–150.00) 148.50 (131.00–164.25) 132.00 (124.00–144.50)#& <0.001 134.00 (122.00–144.00) <0.001 138.50 (123.00–161.00) 0.007 132 (124.25–139.25) <0.001
DBP, mmHg 75.00 (69.00–82.00) 79.00 (72.75–86.25) 72.00 (67.50–80.00)#& <0.001 70.00 (66.00–78.00) <0.001 79.00 (71.75–84.50) 0.048 70.50 (66.25–78.00) 0.004
TC, mmol/L 4.36 (3.80–5.01) 4.96 (4.01–5.97) 4.37 (3.59–5.58)# 0.011 4.08 (3.56–5.58) 0.005 5.32 (4.42–6.29) 0.002 4.25 (3.43–5.37) 0.007
TG, mmol/L 1.24 (0.89–2.10) 1.25 (0.90–1.72) 1.30 (0.98–2.32) 0.470 1.20 (0.89–1.77) 0.922 2.85 (1.31–3.96) 0.002 1.21 (0.96–1.61) 0.961
HDL-C, mmol/L 1.20 (0.96–1.45) 1.22 (1.05–1.44) 1.12 (0.93–1.31) 0.086 1.12 (0.91–1.29) 0.076 1.16 (0.79–1.96) 0.758 1.12 (0.99–1.23) 0.399
LDL-C, mmol/L 2.23 (1.72–2.61) 2.65 (2.05–3.30) 2.35 (1.78–3.19)# 0.005 2.35 (1.80–3.31) 0.004 1.71 (0.89–3.05) 0.001 2.61 (2.09–3.39) 0.001

Data were expressed median (P25P75), or n (%). NC normal cognitive functioning, MCI mild cognitive impairment, BMI body mass index, FBG fasting blood glucose, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, TG total triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, AD Alzheimer’s disease, VaD vascular dementia, OD other type of dementia.

#p < 0.017, MCI group compared with NC group.

$p < 0.017, Dementia group compared with MCI group.

&p < 0.017, Dementia group compared with NC group.